KALA BIO, Inc.
KALA
$5.10
$0.050.99%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 9.33% | -4.52% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 12.57% | -1.14% | |||
| Operating Income | -12.57% | 1.14% | |||
| Income Before Tax | -9.44% | 8.66% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -9.44% | 8.66% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -9.44% | 8.66% | |||
| EBIT | -12.57% | 1.14% | |||
| EBITDA | -12.67% | 1.21% | |||
| EPS Basic | 19.04% | 9.96% | |||
| Normalized Basic EPS | 19.22% | 5.54% | |||
| EPS Diluted | 19.04% | 9.96% | |||
| Normalized Diluted EPS | 19.22% | 5.54% | |||
| Average Basic Shares Outstanding | 35.17% | 1.45% | |||
| Average Diluted Shares Outstanding | 35.17% | 1.45% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||